ZA200803422B - Aryisulfonyichromas as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors - Google Patents
Aryisulfonyichromas as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitorsInfo
- Publication number
- ZA200803422B ZA200803422B ZA200803422A ZA200803422A ZA200803422B ZA 200803422 B ZA200803422 B ZA 200803422B ZA 200803422 A ZA200803422 A ZA 200803422A ZA 200803422 A ZA200803422 A ZA 200803422A ZA 200803422 B ZA200803422 B ZA 200803422B
- Authority
- ZA
- South Africa
- Prior art keywords
- inhibitors
- aryisulfonyichromas
- protein kinase
- indolylmaleimide derivatives
- kinase inhibitors
- Prior art date
Links
- WIQRSJOCVVPMPS-UHFFFAOYSA-N 3-(1h-indol-2-yl)pyrrole-2,5-dione Chemical class O=C1NC(=O)C(C=2NC3=CC=CC=C3C=2)=C1 WIQRSJOCVVPMPS-UHFFFAOYSA-N 0.000 title 1
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000003909 protein kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73294005P | 2005-11-03 | 2005-11-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200803422B true ZA200803422B (en) | 2009-09-30 |
Family
ID=37808173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200803422A ZA200803422B (en) | 2005-11-03 | 2008-04-17 | Aryisulfonyichromas as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors |
Country Status (19)
Country | Link |
---|---|
US (1) | US7754759B2 (zh) |
EP (1) | EP2027104B1 (zh) |
JP (1) | JP2009514828A (zh) |
KR (1) | KR100984897B1 (zh) |
CN (1) | CN101300246A (zh) |
AR (1) | AR056213A1 (zh) |
AT (1) | ATE499355T1 (zh) |
AU (1) | AU2006310612A1 (zh) |
BR (1) | BRPI0618206A2 (zh) |
CA (1) | CA2628173A1 (zh) |
DE (1) | DE602006020351D1 (zh) |
ES (1) | ES2359735T3 (zh) |
IL (1) | IL190868A0 (zh) |
NO (1) | NO20081818L (zh) |
NZ (1) | NZ567285A (zh) |
RU (1) | RU2008115032A (zh) |
TW (1) | TWI327914B (zh) |
WO (1) | WO2007051735A1 (zh) |
ZA (1) | ZA200803422B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8354548B2 (en) * | 2010-02-19 | 2013-01-15 | Bristol-Myers Squibb Company | Glycine chroman-6-sulfonamides for use as inhibitors of diacylglycerol lipase |
CN113200952B (zh) * | 2021-04-13 | 2023-03-10 | 江西师范大学 | 一种串联环化反应合成2-氨基-3,3-二氯代色满酮或2-氨基-3,3-二溴代色满酮的方法 |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3901814A1 (de) * | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
ZA901277B (en) * | 1989-02-27 | 1991-10-30 | Lilly Co Eli | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
US5506192A (en) * | 1990-06-07 | 1996-04-09 | Sandoz Ltd. | Substituted phthalides and heterocyclic phthalides |
JP3210665B2 (ja) * | 1990-07-27 | 2001-09-17 | 中外製薬株式会社 | 新規なベンゾピラン誘導体 |
US5401848A (en) | 1990-11-26 | 1995-03-28 | E. R. Squibb & Sons, Inc. | Indane and quinoline derivatives |
DE4102103A1 (de) | 1991-01-25 | 1992-08-20 | Bayer Ag | Substituierte benzoxazepine und benzthiazepine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
US5817693A (en) * | 1991-11-05 | 1998-10-06 | Cousins; Russell Donovan | Endothelin receptor antagonists |
ZA93436B (en) * | 1992-01-24 | 1993-08-25 | Chugai Pharmaceutical Co Ltd | Benzopyran derivatives |
AU4761693A (en) * | 1992-08-17 | 1994-03-15 | Chugai Seiyaku Kabushiki Kaisha | Benzopyran and benzoxazine derivatives |
US5374643A (en) | 1992-09-11 | 1994-12-20 | E. R. Squibb & Sons, Inc. | Aryl urea (thiourea) and cyanoguanidine derivatives |
US5739135A (en) * | 1993-09-03 | 1998-04-14 | Bristol-Myers Squibb Company | Inhibitors of microsomal triglyceride transfer protein and method |
ATE183184T1 (de) | 1994-01-31 | 1999-08-15 | Pfizer | Neuroprotektive chroman verbindungen |
US6150402A (en) | 1994-08-15 | 2000-11-21 | Loma Linda University Medical Center | Natriuretic compounds |
US5869478A (en) * | 1995-06-07 | 1999-02-09 | Bristol-Myers Squibb Company | Sulfonamido substituted benzopyran derivatives |
PL324319A1 (en) | 1995-06-30 | 1998-05-25 | Upjohn Co | 1,6-disubstituted isochromates for fighting against sick headaches |
US5663194A (en) * | 1995-07-25 | 1997-09-02 | Mewshaw; Richard E. | Chroman-2-ylmethylamino derivatives |
US5935958A (en) * | 1996-07-01 | 1999-08-10 | Schering Corporation | Muscarinic antagonists |
JP2000514060A (ja) | 1996-07-01 | 2000-10-24 | シェーリング コーポレイション | ムスカリン様アンタゴニスト |
US6214881B1 (en) * | 1996-08-21 | 2001-04-10 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
US6559144B2 (en) * | 1997-02-13 | 2003-05-06 | Merck Patent Gesellschaft Mit | Bicyclic amino acids |
PT971878E (pt) * | 1997-02-27 | 2008-07-08 | Takeda Pharmaceutical | Compostos de amina, sua produção e utilização como inibidores da produção de amilóide beta |
TWI242011B (en) * | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
DE19754573A1 (de) * | 1997-12-09 | 1999-06-10 | Bayer Ag | Pharmazeutische Zusammensetzung zur Behandlung von Schlaganfall und Schädel-Hirn-Trauma |
ES2144355B1 (es) | 1997-12-30 | 2001-01-01 | Ferrer Int | Compuestos derivados del cromeno. |
FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6586475B1 (en) * | 1998-11-20 | 2003-07-01 | Takeda Chemical Industries, Ltd. | β-amyloid protein production/secretion inhibitors |
HU226652B1 (en) * | 1998-12-04 | 2009-05-28 | Takeda Pharmaceutical | Benzofuran derivatives, process for preparation of the same and uses thereof |
ES2312423T3 (es) * | 2000-04-03 | 2009-03-01 | Takeda Pharmaceutical Company Limited | Procedimiento para producir derivados de amina. |
JP2004509066A (ja) | 2000-05-10 | 2004-03-25 | スミスクライン・ビーチャム・コーポレイション | 新規抗感染症薬 |
DE10044091A1 (de) * | 2000-09-07 | 2002-04-04 | Merck Patent Gmbh | Chromanonderivate |
AR035605A1 (es) | 2000-12-11 | 2004-06-16 | Bayer Corp | Derivados de aminometil cromano di-sustituidos, un metodo para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la manufactura de medicamentos utiles como agonistas beta-3-adreno-receptores |
AR035858A1 (es) * | 2001-04-23 | 2004-07-21 | Bayer Corp | Derivados de cromano 2,6-sustituidos,composiciones farmaceuticas,uso de dichos derivados para la manufactura de medicamentos utiles como agonistas adrenorreceptores beta-3 |
AR036081A1 (es) | 2001-06-07 | 2004-08-11 | Smithkline Beecham Corp | Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos |
WO2003005356A2 (en) | 2001-07-02 | 2003-01-16 | Koninklijke Philips Electronics N.V. | Waveform equalizer for obtaining a corrected signal and apparatus for reproducing information |
CA2452743A1 (en) * | 2001-08-03 | 2003-02-13 | Pharmacia & Upjohn Company | 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
MXPA04003087A (es) * | 2001-10-04 | 2004-09-06 | Wyeth Corp | Derivados de cromano como ligados de 5-hidroxitriptamina-6. |
WO2003029239A1 (en) * | 2001-10-04 | 2003-04-10 | Wyeth | Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands |
WO2003037262A2 (en) | 2001-10-29 | 2003-05-08 | Smithkline Beecham Corporation | Novel anit-infectives |
AU2003248566A1 (en) | 2002-05-24 | 2003-12-12 | Smithkline Beecham Corporation | Novel anti-infectives |
JP4754821B2 (ja) * | 2002-06-20 | 2011-08-24 | プロキシマゲン・リミテッド | 肥満症、ii型糖尿病およびcns障害の治療に有用な新規化合物 |
SG156524A1 (en) | 2002-06-20 | 2009-11-26 | Biovitrum Ab Publ | New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
US20050075331A1 (en) * | 2003-10-06 | 2005-04-07 | Pratt John K. | Anti-infective agents |
US20040097492A1 (en) * | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
US20040162285A1 (en) * | 2002-11-01 | 2004-08-19 | Pratt John K. | Anti-infective agents |
US7902203B2 (en) * | 2002-11-01 | 2011-03-08 | Abbott Laboratories, Inc. | Anti-infective agents |
AU2003300957A1 (en) | 2002-12-11 | 2004-06-30 | Smithkline Beecham Corporation | Anti-infectives |
AU2003300956A1 (en) | 2002-12-11 | 2004-06-30 | Smithkline Beecham Corporation | Anti-infectives |
AU2003297235A1 (en) | 2002-12-17 | 2004-07-22 | Smithkline Beecham Corporation | Anti-infectives |
WO2005019191A2 (en) | 2003-08-25 | 2005-03-03 | Abbott Laboratories | 1, 1-dioxido-4h-1,2,4-benzothiadiazine derivate und verwandte verbindungen als inhibitoren der hcv polymerase zur behandlung von hepatitis c |
US7795242B2 (en) * | 2003-10-15 | 2010-09-14 | The Brigham And Women's Hospital, Inc. | Methods and compositions for immunomodulation |
US20070208166A1 (en) | 2003-10-24 | 2007-09-06 | Exelixis, Inc. | Tao Kinase Modulators And Method Of Use |
AU2005238179B2 (en) | 2004-05-05 | 2010-08-26 | F. Hoffmann-La Roche Ag | Arylsulfonyl benzodioxanes useful for modulating the 5-HT6 receptor, the 5-HT2A receptor or both |
US7378415B2 (en) * | 2004-09-30 | 2008-05-27 | Roche Palo Alto Llc | Benzoxazine and quinoxaline derivatives and uses thereof |
RU2396255C2 (ru) * | 2004-12-21 | 2010-08-10 | Ф. Хоффманн-Ля Рош Аг | Производные тетралина и индана и их применения |
-
2006
- 2006-10-24 ES ES06807516T patent/ES2359735T3/es active Active
- 2006-10-24 RU RU2008115032/04A patent/RU2008115032A/ru not_active Application Discontinuation
- 2006-10-24 EP EP06807516A patent/EP2027104B1/en active Active
- 2006-10-24 AU AU2006310612A patent/AU2006310612A1/en not_active Abandoned
- 2006-10-24 AT AT06807516T patent/ATE499355T1/de active
- 2006-10-24 JP JP2008538331A patent/JP2009514828A/ja not_active Ceased
- 2006-10-24 CN CNA2006800410298A patent/CN101300246A/zh active Pending
- 2006-10-24 CA CA002628173A patent/CA2628173A1/en not_active Abandoned
- 2006-10-24 NZ NZ567285A patent/NZ567285A/en unknown
- 2006-10-24 DE DE602006020351T patent/DE602006020351D1/de active Active
- 2006-10-24 BR BRPI0618206-2A patent/BRPI0618206A2/pt not_active IP Right Cessation
- 2006-10-24 WO PCT/EP2006/067732 patent/WO2007051735A1/en active Application Filing
- 2006-10-24 KR KR1020087013315A patent/KR100984897B1/ko not_active IP Right Cessation
- 2006-10-31 TW TW095140241A patent/TWI327914B/zh active
- 2006-11-01 AR ARP060104782A patent/AR056213A1/es unknown
- 2006-11-03 US US11/592,685 patent/US7754759B2/en not_active Expired - Fee Related
-
2008
- 2008-04-14 IL IL190868A patent/IL190868A0/en unknown
- 2008-04-15 NO NO20081818A patent/NO20081818L/no not_active Application Discontinuation
- 2008-04-17 ZA ZA200803422A patent/ZA200803422B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2628173A1 (en) | 2007-05-10 |
CN101300246A (zh) | 2008-11-05 |
DE602006020351D1 (en) | 2011-04-07 |
AU2006310612A1 (en) | 2007-05-10 |
JP2009514828A (ja) | 2009-04-09 |
TW200800163A (en) | 2008-01-01 |
ES2359735T3 (es) | 2011-05-26 |
IL190868A0 (en) | 2008-11-03 |
ATE499355T1 (de) | 2011-03-15 |
EP2027104A1 (en) | 2009-02-25 |
US7754759B2 (en) | 2010-07-13 |
US20070099908A1 (en) | 2007-05-03 |
KR20080074935A (ko) | 2008-08-13 |
AR056213A1 (es) | 2007-09-26 |
EP2027104B1 (en) | 2011-02-23 |
RU2008115032A (ru) | 2009-12-10 |
TWI327914B (en) | 2010-08-01 |
KR100984897B1 (ko) | 2010-10-01 |
NZ567285A (en) | 2010-06-25 |
NO20081818L (no) | 2008-06-19 |
BRPI0618206A2 (pt) | 2011-08-23 |
WO2007051735A1 (en) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL186526A0 (en) | Substituted amide derivatives as protein kinase inhibitors | |
TWI370127B (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
IL196554A0 (en) | Heteroaryl derivatives as protein kinase inhibitors | |
HK1146042A1 (en) | Pyrimidine derivatives as protein kinase inhibitors | |
IL186845A0 (en) | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors | |
SI1893612T1 (sl) | Pirolo b piridin derivati kot protein kinazni inhibitorji | |
IL190598A0 (en) | Pyrazolopyrimidines as protein kinase inhibitors | |
IL173380A0 (en) | Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors | |
SI2201012T1 (sl) | Derivati pirolo(2,3-D)pirimidina kot inhibitorji proteina kinaze B | |
IL187310A0 (en) | Bicyclic derivatives as p38 kinase inhibitors | |
IL191294A0 (en) | Imidazopyrazines as protein kinase inhibitors | |
HK1135391A1 (en) | Triazole derivatives as kinase inhibitors | |
HK1145496A1 (zh) | 作為蛋白酪氨酸激酶抑制劑的雙環雜環化合物 | |
HK1145495A1 (zh) | 作為蛋白酪氨酸激酶抑制劑的雙環雜環化合物 | |
ZA200709269B (en) | Protein kinase inhibitors | |
IL188027A0 (en) | Bicyclic derivatives as p38 kinase inhibitors | |
IL194491A0 (en) | Thiazolyldihydroindazole derivatives as protein kinase inhibitors | |
ZA200703835B (en) | Heterocyclic substituted bisarylurea derivatives as kinase inhibitors | |
ZA200803422B (en) | Aryisulfonyichromas as 5-HT6 inhibitors indolylmaleimide derivatives as protein kinase inhibitors | |
ZA200810573B (en) | Substituted 3-cyanopyridines as protein kinase inhibitors | |
ZA200709732B (en) | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors | |
ZA200706212B (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors |